Local Anaesthetic Systemic Toxicity: Early Signs to Know

Local anaesthetics are among the most widely used drugs in clinical practice, injected daily by clinicians in emergency departments, operating theatres, dental surgeries, dermatology clinics, and general practice. Systemic toxicity is uncommon, but it is not rare enough to ignore, and its presentation is frequently missed at the stage where intervention is easiest. Anyone who injects local anaesthetic should be able to recognise the early picture and know where the rescue treatment is kept.

Key points

• Early LAST is usually neurological and subjective: perioral numbness, metallic taste, tinnitus, agitation, confusion.
• Onset is classically within minutes of injection but delayed presentations up to an hour or more are well described, particularly after large-volume infiltration or continuous infusion.
• Cardiovascular signs may be the first manifestation, especially under general anaesthesia or heavy sedation where neurological prodrome is masked.
• Management priorities are stopping the injection, airway and oxygenation, seizure control, and early lipid emulsion therapy.
• Prevention — lowest effective dose, ultrasound guidance, incremental injection with aspiration, and vigilance in high-risk patients — prevents far more cases than treatment rescues.

Why it happens

Local anaesthetics block voltage-gated sodium channels. When plasma concentrations rise beyond the threshold for local action — through inadvertent intravascular injection, rapid absorption from a vascular tissue bed, or cumulative dosing — those channels are blocked in the central nervous system and myocardium as well. The central nervous system is more sensitive, which is why neurological signs usually precede cardiac ones. Beyond sodium channel blockade, the more lipophilic and potent agents also disrupt mitochondrial fatty acid transport and myocardial energetics, which explains why cardiac arrest from these agents can be prolonged and refractory.

Risk is a function of dose, site, patient, and technique. Absorption is fastest from intercostal and interpleural sites and from highly vascular mucosa, slower from subcutaneous tissue. Patients at the extremes of age, those with low muscle mass or low protein binding capacity, those with hepatic impairment, cardiac conduction disease, or significant metabolic acidosis, and pregnant patients all tolerate less. Acidosis worsens toxicity by increasing the ionised fraction and trapping drug intracellularly.

The early picture

Neurological prodrome

The classic sequence begins with symptoms the patient reports rather than signs you observe. Circumoral or lingual numbness and tingling, a metallic taste, tinnitus, blurred or double vision, light-headedness, and a sense of unease or impending doom. Then come objective signs of cortical excitation as inhibitory pathways are blocked first: agitation, slurred or rambling speech, muscle twitching, tremor, and finally generalised seizure. With rising concentrations, excitation gives way to depression — obtundation, respiratory depression, coma.

The practical failure mode is attribution. An anxious patient becoming agitated during a block is easy to label as anxiety or a vasovagal episode. A complaint of ringing ears or a strange taste after a dental injection is easy to dismiss. Treat any new neurological symptom after local anaesthetic administration as LAST until you have a better explanation, and act on it before it progresses.

Cardiovascular features

Early cardiovascular signs may be hypertension and tachycardia from central excitation, which can mislead. Progression brings bradycardia, conduction delay with widened QRS, ventricular arrhythmias including ventricular tachycardia and fibrillation, profound hypotension from myocardial depression and vasodilatation, asystole, and cardiac arrest. In an anaesthetised or deeply sedated patient, or one under regional block with sedation, the neurological prodrome is invisible — the first sign will be a rhythm change or a fall in blood pressure. Any unexplained arrhythmia or haemodynamic deterioration in a patient who has recently received local anaesthetic should raise the question.

Timing

Immediate onset during or seconds after injection suggests direct intravascular delivery. Onset over five to thirty minutes suggests absorption from the tissue bed. Later presentations occur with large-volume infiltration such as tumescent technique, with continuous catheter infusions, and in patients whose clearance is impaired. This is why patients should be monitored and observed after significant blocks rather than sent away immediately, and why the possibility should stay on your list for at least the first hour.

Immediate management

The first actions require no equipment beyond what is already in the room.

1. Stop injecting. Immediately, at the first suspicion, before you have a diagnosis.
2. Call for help and get the rescue kit. State clearly that you suspect local anaesthetic toxicity so the right resources arrive.
3. Airway and oxygenation. Give high-concentration oxygen and support ventilation. Hypoxia, hypercarbia, and acidosis all amplify toxicity; correcting them is genuinely therapeutic, not merely supportive.
4. Control seizures. Benzodiazepines are first line. Avoid large doses of propofol in a haemodynamically unstable patient, and do not rely on it as the lipid component of treatment — it is not a substitute for lipid emulsion.
5. Lipid emulsion therapy. Give intravenous lipid emulsion early, following your institution's protocol, at the point of serious neurological or cardiovascular signs rather than waiting for arrest. Every clinical area where local anaesthetic is injected should hold lipid emulsion with a printed dosing chart, and every clinician who injects should know its location without having to ask.
6. Cardiovascular support. If arrest occurs, run standard resuscitation with modifications: reduced adrenaline dosing per protocol, avoidance of vasopressin, calcium channel blockers, beta blockers, and further local anaesthetic including lidocaine for arrhythmia. Resuscitation may need to be prolonged; recovery after extended arrest is documented, and cardiopulmonary bypass or extracorporeal support should be considered early where available.
7. Observe afterwards. Continue monitoring for several hours after apparent recovery, as recurrence has been reported.

Prevention that actually works

Use the lowest effective dose and volume for the block you are performing, and calculate the maximum for that patient's weight and comorbidity rather than working from habit. Inject incrementally with intermittent aspiration, pausing between aliquots and talking to the patient throughout — the conversation is a monitor. Consider a test dose with a marker where the technique supports it. Use ultrasound guidance for deep or high-volume blocks; it reduces the vascular puncture rate and the volume required. Be more conservative at vascular sites and in patients with reduced physiological reserve.

System factors matter as much as technique. Standard monitoring for significant blocks, an accessible and in-date lipid emulsion kit with a checklist, and a team that has rehearsed the sequence turn a rare emergency into a manageable one. Departments that run a short simulation of LAST find gaps — the missing kit, the unknown location, the hesitation over dosing — at a time when finding them costs nothing.

You can practise this topic with cited sources and a virtual patient at app.medicaltraining.ai.

Educational content for healthcare professionals. It is not medical advice and does not replace clinical judgement or local protocols.